Loading insider details...
Beta
Latest Form 4 (Oct 16, 2026): Sale of 25,000 AQST shares, $105.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 16, 2026 | Aquestive Therapeutics, Inc. (AQST) | Sale | 25,000 | $105.6K |
| Sep 16, 2026 | Aquestive Therapeutics, Inc. (AQST) | Sale | 25,000 | $120.5K |
| Sep 9, 2026 | Aquestive Therapeutics, Inc. (AQST) | In-the-Money Exercise | 91,743 | $88.1K |
| Aug 18, 2026 | Aquestive Therapeutics, Inc. (AQST) | Sale | 25,000 | $107.2K |
| Jul 17, 2026 | Aquestive Therapeutics, Inc. (AQST) | Sale | 4,631 | $18.7K |
| Jun 16, 2026 | Aquestive Therapeutics, Inc. (AQST) | Sale | 25,000 | $104.0K |
| May 18, 2026 | Aquestive Therapeutics, Inc. (AQST) | Sale | 8,257 | $35.4K |
| May 7, 2026 | Aquestive Therapeutics, Inc. (AQST) | Tax Withholding | 335,922 | $1.40M |
| Apr 13, 2026 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 293,100 | n/a |
| Mar 11, 2026 | Aquestive Therapeutics, Inc. (AQST) | Grant/Award | 262,000 | n/a |